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1. Introduction 
Hypoglycin (L-2-amino-3-methylenecyclopropyl- 
propionic acid), the toxic principle of the Jamaican 
ackee fruit (Blighia sapida) [1-4], is converted in
vivo to methylenecyclopropyl acetyl-CoA (MCPA- 
CoA) [5]. This metabolite is thought to inhibit fatty 
acid oxidation [6], following administration f hypo- 
glycin to animals, thereby indirectly causing hypogly- 
caemia [2-4]. Here we show that in the presence of 
methylenecyclopropylacetate (MCPA) fatty acids of 
chain-lengths greater than Ca are oxidised in isolated 
mitochondria ata decreased rate and only as far as 
butyrate. This is due to deacylation of short-chain 
acyl-CoA in the matrix accumulating asa result of the 
powerful and specific inhibition of butyryl-CoA de- 
hydrogenase (EC 1.3.99.2) by MCPA-CoA. 
2. Materials and methods 
Hypoglycin and MCPA were prepared essentially by 
published methods [5,7] and acyl-carnitine and acyl- 
CoA esters were synthesised and characterised as describ- 
ed previously [8,9]. Rat liver mitochondria were 
isolated in 0.3 mM mannitol 2.5 mM 2(N-hvdroxy- 
ethylpiperazin-N'-yl) ethanesulphonate, 0.1 mM 
ethyleneglycol-2-(aminoethyl)-tetraacetate, pH 7.2 
[8]. Oxygen uptake by mitochondria n state 3 [9] 
was recorded polarographically in 3.0 ml of medium 
at 30°C containing 100 mM KC1, 20 mM 3-(N-mor- 
pholino) propanesulphonate, 2.5 mM phosphate, 5 
mM MgC12,1.0 mM EDTA, 10 mM malonate, 2.0 mM 
ADP and 9 m~ defatted bovine serum albumin, pH 
7.2. With these conditions acyl groups are quantitatively 
converted to acetoacetate and the oxygen uptake is a 
direct measure of the flux through/3-oxidation [8]. 
Extracts of acetone-dried rat liver mitochondria (2 g) 
were made by stirring with 10 ml of 10 mM potassium 
phosphate, pH 7.2 at 0°C, followed by centrifugat- 
ion (4.5 X 10 6 g min) and passage through acolumn 
of Sephadex G25 pre-equilibrated with phosphate 
buffer. Protein was measured by a biuret method [8]. 
Acyl-CoA dehydrogenase activities (EC 1.3.99.-) 
were assayed at 20°C and pH 7.2 with 60 taM acyl- 
CoA as substrate [10]. Acyl-CoA hydrolase (EC 3.1. 
2.-) activity was assayed spectrophotometrically at 
324 nm and 20°C in 20 mM phosphate, pH 7.2, using 
0.5 mM aldrithiol-4 to follow CoA.SH released. 
3. Results and discussion 
The rate and extent of oxidation of most even-chain 
acyl-carnitines were decreased, and that of hexanoyl- 
carnitine and butyryl-carnitine was completely block- 
ed, following pre-incubation f liver mitochondria 
with MCPA (fig. 1). The degree of impairment of ox- 
idation of each substrate was independent of the con- 
centration of MCPA in the range 10/aM-0 mM, al- 
though at lower concentrations longer pre-incubation 
(up to 15 min) was necessary to get maximun inhibit- 
ion. 
Inhibition of oxidation of butyryl-carnitine is x- 
plained by the lack of detectable butyryl-CoA dehydr- 
ogenase activity after sonication of liver mitochondria 
that had been incubated with MCPA [11] or isolated 
from livers of hypoglycaemic rats 4 h after administ- 
ration of hypoglycin [11, 12]. By contrast, palmitoyl- 
CoA (octanoyl-CoA) dehydrogenase (EC 1.3.09.3) 
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Fig.1. Inhibition by MCPA of the state 3 rate of oxidation of acyl-carnitines in rat liver mitochondria. Mitochondria (10 mg of 
protein) were added where indicated (by unlabelled arrows); 20 uM decanoyl-carnitine or 10 uM palmitoyl-carnitine and 1.0 mM 
MCPA were then added as shown. The rates of oxygen uptake (ng atom O/min/mg of protein) during a pulse of acyl-carnitine 
oxidation are given in parentheses. The amount of oxygen consumed (ng atom O) on addition of acyl-carnitine is indicated by 
the vertical arrows; the upper one for each pulse gives the apparent increase, and the lower one the apparent contribution of 
endogenous respiration. For the control pulses the sum of these values was close to that required for the complete oxidation 
of acyl-carnitines to acetoacetate and this indicated that endogenous respiration was suppressed. 
[ 10] was not inhibited [11 ]. Palmitoyl-carnitine ox- 
idation was unimpaired in mitochondria uncoupled 
by addition of 0.2/aM trifluoromethoxycarbonylcy- 
anide phenylhydrazone, 10 mM arsenate and valinomy- 
cin (0.2 mg/ml) even after prolonged incubation with 
1.0 mM MCPA, indicating that prior conversion of 
MCPA to MCPA-CoA by butyryl-CoA (medium chain 
acyl-CoA) synthetase (EC 6.2.1.2)  in the matrix is 
necessary for inhibition (see [8] ). We have failed to 
prepare MCPA-CoA, either chemically or enzymically 
using purified butyryl-CoA synthetase [ 13], suggest- 
ing that MCPA-CoA is very unstable. However, there 
was a progressive and apparently irreversible inactiva- 
tion of butyryl-CoA dehydrogenase (fig. 2) when pur- 
ified ox liver butyryl-CoA dehydrogenase [10] and 
rat liver butyryl-CoA synthetase, orextracts of rat 
liver mitochondria, were incubated with MCPA, CoA- 
SH and MgATP (all of which were necessary for inact- 
ivation), indicating that MCPA-CoA is the inhibitory 
species derived from hypoglycin. 
The decrease in the percentage actually consumed 
of the theoretical oxygen uptake required for compl- 
ete oxidation of acyl-camitine toacetoacetate, increas- 
ed with decreasing chain-length from palmitoyl-carnitine 
to octanoyl-carnitine  MCPA-inhibited mitochondria. 
This agrees quantitatively with conversion of acyl-CoA, 
generated i n the matrix from exogenous acyl-carnitine, 
to butyrate and acetoacetate (fig.3), for example. 
Palmitoyl-CoA + 602 ~ 3 Acetoacetate + Butyrate 
+ CoA.SH. The total CoA.SH content of rat liver 
mitochondria s about 3 nmol/mg of protein [8] which 
is much less than the amount of acyl-carnitine that can 
be oxidised (at least 10 nmol/mg mitochondrial protein, 
not shown) so that repeated recycling of CoA.SH 
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Fig.2. Inactivation of butyryl-CoA dehydrogenase by a meta- 
bolite of MCPA. Purified ox liver butyryl-CoA dehydrogenase 
(50 nU) and rat liver butyryl-CoA synthetase (1 nU) (o), or 
extracts of rat liver mitochondria (8 mg protein/ml) (G), were 
incubated with 0.5 mM MCPA, 0.04 mM CoA.SH and 10 mM 
MgATP at 30°C in 10 mM phosphate, pH 7.2. Butyryl-CoA 
dehydrogenase was assayed at various times during the 
incubation. 
must occur. As predicted for these considerations, 
extracts of rat liver mitochondria r pidly deacylated 
butyryl-CoA and hexanoyl-CoA (apparent K M values of 
2 mM and 0.5 hexanoyl-CoA (apparent K M values of 
2 mM and 0.5 mM, and V m values of 10 and 15 nmol/ 
mg of protein respectively). This activity is latent in 
intact mitochondria and is released by sonication. 
Approximately the predicted amounts of free butyrate 
and only traces ofhexanoate were detected by g.l.c. 
[14] as products of the oxidation of palmitoyl-carnitine 
in MCPA-inhibited mitochondria, while very little of 
these acids was formed in the absence of MCPA. Further. 
butyrate occurs in the blood of animals poisoned with 
hypoglycin [15]. The presence of short-chain acyl-CoA 
hydrolase with a high K M in the matrix would oppose 
complete acylation of intramitochondrial CoA.SH by 
some unusual short-chain fatty acids, although norm- 
ally intermediates of fl-oxidation do not accumulate 
sufficiently to be deacylated [16, 17]. Similar deacy- 
lase activities have also been reported recently in mit- 
ochondria from several tissues [I 8-20].  
The pattern of inhibition of oxidation of different 
acyl-carnitines by MCPA (fig. 3) contrasts with the 
earlier eport hat formation of 14 C02 from free long- 
chain I-[14 C] -labelled fatty acids in rat liver mitoch- 
ondria is impaired more strongly than from those of 
shorter-chain length [6]. However, formation of in- 
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Fig.3. Characteristics of the inhibition by MCPA of the oxidation of acyl-carnitines of different chain-lengths. The rate and 
amount of oxygen uptake on adding 10 ~tM acyl-carnitines were recorded as described in the legend to fig. 1. (a) Rate of oxygen 
uptake; control (o), inhibited (o); (b) percentage inhibition of control rates of acyl-carnitine oxidations (Q); (c) theoretical nd 
oberved percentage decreases in the size of the MCPA-inhibited pulses for the partial oxidation of acyl-carnitines compared with 
uninhibited pulses (fig.l); theoretical values for oxidation, as for as butyryl-CoA (o), as fa~ as hexanoyl-CoA (0), observed values 
assuming that endogenous respiration, continues (LX), or is suppressed (e). 
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hibitory MCPA-CoA in the matrix may be prevented 
by competition with high concentraions of those short- 
er medium-chain fatty acids which are also substrates 
for butyryl-CoA synthetase, but not by long-chain 
fatty acids which are activated outside (see [8] ). 
The inability of MCPA-inhibited mitochondria to 
oxidise hexanoylcarnitine can be explained if it is 
assumed that there is some structural organisation of 
the enzymes of/3-oxidation (see [ 17]). Hexanoyl-CoA 
generated from long-chain acyl-CoAs by/3-oxidation 
may have privileged access to palmitoyl-CoA dehydro- 
genase, compared with that formed in the matrix from 
exogenous hexanoyl-carnitine which may only be a 
substrate for butyryl-CoA dehydrogenase. This explan- 
ation also assumes that butyryl-CoA formed either by 
/3-oxidation or from exogenous butyryl-carnitine is 
only a substrate for butyryl-CoA dehydrogenase. Slow- 
ing of/3-oxidation by MCPA is presumably caused by 
short-chain acyl-CoA accumulating up to a critical 
concentration set by the relatively high K M of acyl- 
CoA hydrolase, following inhibition of butyryl-CoA 
dehydrogenase. Impaired/~-oxidation, together with 
inhibition of isovaleryl-CoA dehydrogenase [ I 1, 12, 15] 
and the probable inhibition of glutaryl~CoA de- 
hydrogenase by MCPA-CoA [15], can explain most of 
the pharmacological effects of hypoglycin. 
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